Analysis of 3 High-Dividend Healthcare Stocks Highlighted by Top Wall Street Analysts
Unlock More Features
Login to access AI-powered analysis, deep research reports and more advanced features

About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
Related Stocks
The Benzinga article [1] focuses on three healthcare stocks with high dividend yields, a segment attractive to investors during market turbulence for perceived stability and regular income. As of 2025-12-01, real-time quotes [0] show CVS trading at $80.36 (+0.63% daily), BMY at $49.20 (-0.10% daily), and VTRS at $10.70 (+0.52% daily). Over the 30-day period (2025-10-17 to 2025-11-28) [0], BMY exhibited the strongest performance with a 13.68% gain, followed by VTRS at +5.95%, while CVS declined by 1.28%. Notably, the healthcare sector was the worst-performing sector on 2025-12-01, registering a -0.01725% change [0], contrasting with the mostly positive daily moves of the highlighted stocks, suggesting company-specific factors may be influencing their performance.
- Dividend yield and short-term performance vary significantly among the three stocks: BMY offers the highest yield (5.04%) paired with the strongest 30-day price appreciation (13.68%), potentially indicating market confidence in its dividend sustainability and overall performance.
- The healthcare sector’s underperformance on the article’s release date [0] contrasts with the mixed but mostly positive daily performance of the three stocks, suggesting these dividend-paying names may be outperforming sector peers due to unique fundamentals or targeted investor sentiment.
Opportunities: The high dividend yields of these stocks position them as potential choices for investors seeking income during market uncertainty [1]. BMY’s strong 30-day performance [0] further enhances its appeal as a high-yield, growing investment.
Risks: The healthcare sector’s underperformance on 2025-12-01 [0] could signal broader sector headwinds. CVS’s 30-day decline [0] warrants consideration of company-specific challenges. Additionally, the article does not provide detailed free cash flow data, critical for assessing long-term dividend sustainability.
- CVS Health (CVS): Dividend yield 3.31%, $80.36 (+0.63% daily), 30-day performance -1.28% [0,1]
- Viatris Inc (VTRS): Dividend yield 4.49%, $10.70 (+0.52% daily), 30-day performance +5.95% [0,1]
- Bristol-Myers Squibb Co (BMY): Dividend yield 5.04%, $49.20 (-0.10% daily), 30-day performance +13.68% [0,1]
- Healthcare sector: -0.01725% performance on 2025-12-01 [0]
Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
